Diagnostic value of conventional visual evoked potentials applied to patients with multiple sclerosis

Medicina

Volumn 47, Issue 5, 2011, Pages 263-269

  Balnyte, Renata ^a   Uloziene, Ingrida ^a   Rastenyte, Daiva ^a   Vaitkus, Antanas ^a   Malciene, Lina ^a,b   Laučkaite, Kristina ^a  

^a LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^b KLAIPEDA UNIVERSITY   (Lithuania)

Author keywords

Conventional visual evoked potentials; Multiple sclerosis; Neurological systems.

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; EVOKED VISUAL RESPONSE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; VALIDATION STUDY; VISUAL SYSTEM EXAMINATION;

ADOLESCENT; ADULT; AGED; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; EVOKED POTENTIALS, VISUAL; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 80053321516     PISSN: 00257729     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Walsh P, Kane N, Butler S. The clinical role of evoked potentials. J Neurol Neurosurg Psychiatry 2005;76:16-22.
2. Chiappa K. Evoked potentials in clinical medicine. 2nd ed. New York: Raven Press; 1983.
3. Beer S, Rösler KM, Hess CW. Diagnostic value of paraclinical tests in multiple sclerosis: relative sensitivities and specificities for reclassification according to the Poser committee criteria. J Neurol Neurosurg Psychiatry 1995;59:152-9.
4. Murray TJ. Diagnosis and treatment of multiple sclerosis. BMJ 2006;332:525-7.
5. Siva A, Saip S, Altintas A, Jacob A, Keegan BM, Kantarci OH. Multiple sclerosis risk in radiologically uncovered asym ptomatic possible inflammatory-demyelinating disease. Mult Scler 2009;15:918-27.
6. Comi G, Leocani L, Medaglini S, Locatelli T, Martinelli V, Santuccio G, et al. Measuring evoked responses in multiple sclerosis. Mult Scler 1999;5(4):263-7.
7. Naismith RT, Tutlam NT, Xu J, Shepherd JB, Klawiter EC, Song SK, et al. Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis. Neurology 2009;73(1):46-52.
8. Trip SA, Miller DH. Imaging in multiple sclerosis. J Neurol Neurosurg Psychiatry 2005;76:11-8.
9. Weinstock-Guttman B, Baier M, Stockton R, Weinstock A, Justinger T, Munschauer F, et al. Pattern reversal visual evoked potentials as a measure of visual pathway pathology in multiple sclerosis. Mult Scler 2003;9(5):529-34.
10. Gareau PJ, Gati JS, Menon RS, Lee D, Rice G, Mitchell JR, et al. Reduced visual evoked responses in multiple sclerosis patients with optic neuritis: comparison of functional magnetic resonance imaging and visual evoked potentials. Mult Scler 1999;5(3):161-4.
11. Davies MB, Williams R, Haq N, Pelosi L, Hawkins CP. MRI of optic nerve and postchiasmal visual pathways and visual evoked potentials in secondary progressive multiple sclerosis. Neuroradiology 1998;40:765-70.
12. Kallmann BA, Fackelmann S, Toyka KV, Rieckmann P, Reiners K. Early abnormalities of evoked potentials and future disability in patients with multiple sclerosis. Mult Scler 2006;12(1):58-65.
13. Fuhr P, Borggrefe-Chappius A, Schindler C, Kappos L. Visual and motor evoked potentials in the course of multiple sclerosis. Brain 2001;124:2162-8.
14. Grover LK, Hood DC, Ghadiali Q, Grippo TM, Wenick AS, Greenstein VC, et al. A comparison of multifocal and conventional visual evoked potential techniques in patients with optic neuritis/multiple sclerosis. Doc Ophthalmol 2008;117:121-8.
15. Freedman MS. 'Time is brain' also in multiple sclerosis. Mult Scler 2009;15:1133-4.
16. Kolappan M, Henderson APD, Jenkins TM, Wheeler-Kingshott CAM, Plant GT, Thompson AJ, et al. Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis. J Neurol 2009;256(3):305-19.
17. Mezer E, Bahir Y, Leibu R, Perlman I. Effect of defocusing and of distracted attention upon recordings of the visual evoked potential. Doc Ophthalmol 2004;109:229-38.
18. Sisto D, Trojano M, Vetrugno M, Trabucco T, Iliceto G, Sborgia C. Subclinical visual involvement in multiple sclerosis: a study by MRI, VEPs, frequency-doubling perimetry, standard perimetry, and contrast sensitivity. Invest Ophthalmol Vis Sci 2005;46:1264-8.
19. Klistorner A, Arvind H, Nguyen T, Garrick R, Paine M, Graham S, et al. Fellow eye changes in optic neuritis correlate with the risk of multiple sclerosis. Mult Scler 2009; 15:928-32.
20. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria." Ann Neurol 2005;58:840-6.
21. Groseth GS, Ashman EJ. Practice parameter: the usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidenced based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;54:1720-5.
22. Feinsod M, Hoyt WF. Subclinical optic neuropathy in multiple sclerosis: how early VER components reflect axon loss and conduction defects in optic pathways. J Neurol Neurosurg Psychiatry 1975;38:1109-14.
23. Pueyo V, Martin J, Fernandez J, Almarcegui C, Ara J, Egea C, et al. Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis. Mult Scler 2008;14(5):609-14.
24. Holder GE, Gale RP, Acheson JF, Robson AG. Electrodiagnostic assessment in optic nerve disease. Curr Opin in Neurol 2009;22(1):3-10.
25. Hande T, Murat T, Oytun B, Nilgun C, Musa O, Onder U. Visual evoked potentials in differential diagnosis of multiple sclerosis and neurobehcet's disease. Tohoku J Exp Med 2008;216:109-16.
26. Hidajat RR, Goode DH. Normalisation of visual evoked potentials after optic neuritis. Doc Ophthalmol 2003;106:305-9.
27. Brusa A, Jones SJ, Plant GT. Long-term remyelination after optic neuritis. A 2-year visual evoked potential and psychophysical serial study. Brain 2001;124:468-79.
28. Coyle P, Arnason B, Hurwitz B, Lublin F. Optimizing outcomes in multiple sclerosis - a consensus initiative. Mult Scler 2009;15:S5-35.
29. Fraser C, Klistorner A, Graham S, Garrick R, Billson F, Grigg J. Multifocal visual evoked potential latency analysis: predicting progression to multiple sclerosis. Arch Neurol 2006;63:847-50.
30. Lascano AM, Brodbeck V, Lalive PH, Chofflon M, Seeck M, Michel CM. Increasing the diagnostic value of evoked potentials in multiple sclerosis by quantitative topographic analysis of multichannel recordings. J Clin Neurophysiol 2009;26(5):316-25.
31. Celesia GG, Brigell MG. Recommended standards for pattern electroretinograms and visual evoked potentials. In: Deuschl G, Eisen A, editors. Recommendations for the practice of clinical neurophysiology: guidelines of the International Federation of Clinical Physiology (EEG, suppl 52). Elsevier Science; 1999.
32. Courtney AM, Treadaway K, Remington G, Frohman E. Multiple sclerosis. Med Clin N Am 2009;93:451-76.
33. Mizota A, Asaumi N, Takasoh M, Adachi-Usami E. Pattern visual evoked potentials in Japanese patients with multiple sclerosis without history of visual pathway involvement. Doc Ophthalmol 2007;115:105-9.
34. Nix WA. Electrophysiological sequels of inflammatory demyelination. J Neurol Neurosurg Psychiatry 1994;57:29-32.